Printer Friendly
The Free Library
14,679,167 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

MINIMED PUSHING GLUCOSE SENSOR.


Byline: Ben Sullivan Daily News Staff Writer

Sylmar-based MiniMed Inc. said Wednesday that it has applied to the U.S. Food and Drug Administration for approval of a continuous blood-sugar sensor.

If approved, the sensor would be used in a family of devices to help diabetics and physicians monitor patients' blood glucose levels blood glucose level,
n level of glu-cose in the bloodstream, normally about 70 to 115 mg/dL after fasting overnight. Higher levels may indicate diseases such as diabetes mellitus.
.

The worldwide market for blood glucose blood glucose Diabetology The principal sugar produced by the body from food–especially carbohydrates, but also from proteins and fats; glucose is the body's major source of energy, is transported to cells via the circulation and used by cells in the presence  tests is approximately $3 billion annually.

Diabetics currently keep tabs on tab 1  
n.
1. A projection, flap, or short strip attached to an object to facilitate opening, handling, or identification.

2. A small, usually decorative flap or tongue on a garment.

3.
 their glucose levels with meters that require the user to prick their finger and draw a drop of blood. With the MiniMed device, a catheter catheter /cath·e·ter/ (kath´e-ter)
1. a tubular, flexible surgical instrument that is inserted into a cavity of the body to withdraw or introduce fluid.

2. urethral c.
 would be inserted below the patient's skin and kept in place for one or more days.

MiniMed also markets insulin-infusion pumps that diabetics wear to keep a steady supply of insulin insulin, hormone secreted by the β cells of the islets of Langerhans, specific groups of cells in the pancreas. Insufficiency of insulin in the body results in diabetes. Insulin was one of the first products to be manufactured using genetic engineering.  available to their blood. MiniMed President Terrance Gregg said in a prepared statement that once approved, the new sensors will both generate revenues on their own and boost sales of the insulin-infusion pumps.

MiniMed shares closed down $2.25 to $36.75.
COPYRIGHT 1997 Daily News
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1997, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Title Annotation:BUSINESS
Publication:Daily News (Los Angeles, CA)
Geographic Code:1USA
Date:Dec 18, 1997
Words:168
Previous Article:RIVAL FIRM TO TAKE OVER CHATSWORTH COMPANY.(BUSINESS)
Next Article:BURBANK FIRM WIDENS GRIP ON POST-PRODUCTION; FOUR MEDIA PLANS TO BUY POP.(BUSINESS)
Topics:



Related Articles
MiniMed Investments Strengthen Market Advantage.(Brief Article)
MINIMED MAY GET IMPLANT RIGHTS.(Business)
MINIMED SHARES TAKE HIT.(Business)
MINIMED DOUBLES 4TH-QUARTER PROFITS.(BUSINESS)
MINIMED OPENS STRONG THEN FADES FOR MILD GAIN.(Business)(Statistical Data Included)
MINIMED TEST DEVICE GAINS OK FROM PANEL.(BUSINESS)
INSULIN PUMP, NEW SENSOR KEEP MINIMED OUTLOOK HOT.(Business)(Statistical Data Included)
MINIMED EARNINGS SET RECORD; SYLMAR FIRM EXPECTS GROWTH TO CONTINUE.(BUSINESS)(Statistical Data Included)
SENSOR COULD ASSIST BUSINESS; DEVICE MAY AID MINIMED.(BUSINESS)(Review)
MINIMED SHARES UP 10 PERCENT; HEARING DATE SET FOR DIABETES DEVICE.(Business)

Terms of use | Copyright © 2009 Farlex, Inc. | Feedback | For webmasters | Submit articles